Incidence of nephrolithiasis in relation to environmental exposure to lead and cadmium in a population study

Environmental Research

Volumn 145, Issue , 2016, Pages 1-8

  Hara, Azusa ^a   Yang, Wen Yi ^a   Petit, Thibault ^a   Zhang, Zhen Yu ^a   Gu, Yu Mei ^a   Wei, Fang Fei ^a   Jacobs, Lotte ^a   Odili, Augustine N ^a,b   Thijs, Lutgarde ^a   Nawrot, Tim S ^c   Staessen, Jan A ^a,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ABUJA   (Nigeria)

^c HASSELT UNIVERSITY   (Belgium)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cadmium; Lead; Nephrolithiasis; Population science; Risk stratification

Indexed keywords

CADMIUM; CALCIUM; GLUCOSE; LEAD; MAGNESIUM; THIAZIDE DIURETIC AGENT; URIC ACID; POLLUTANT;

CADMIUM; CALCIUM; DIGESTIVE SYSTEM DISORDER; DISEASE INCIDENCE; ENVIRONMENTAL RISK; HOMEOSTASIS; LEAD; MAGNESIUM; PARTICIPATORY APPROACH; POLLUTION EXPOSURE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SPATIOTEMPORAL ANALYSIS; URINE;

ADULT; AGE; AGED; ARTICLE; BELGIUM; CADMIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEAVY METAL BLOOD LEVEL; HUMAN; INCIDENCE; LEAD BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEPHROLITHIASIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX; SMOKING; URINE VOLUME; WAIST HIP RATIO; ADVERSE EFFECTS; ANALYSIS; BLOOD; CHEMICALLY INDUCED; HEALTH SURVEY; MIDDLE AGED; POLLUTANT; TOXICITY; VERY ELDERLY; YOUNG ADULT;

BELGIUM;

ADULT; AGED; AGED, 80 AND OVER; BELGIUM; CADMIUM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; INCIDENCE; LEAD; MALE; MIDDLE AGED; NEPHROLITHIASIS; POPULATION SURVEILLANCE; YOUNG ADULT;

EID: 84947967208     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2015.11.013     Document Type: Article

References (60)

1. 41st World Medical Assembly, 1990. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Bulletin of the Pan American Health Organization. 24, pp. 606-609.
2. Angle C.R., Thomas D.J., Swanson S.A. Osteotoxicity of cadmium and lead in HOS TE 85 and ROS 17/2.8 cells: relation to metallothionein induction and mitochondrial binding. Biometals 1993, 6:179-184.
3. Åkesson A., Lundh T., Vahter M., Bjellerup P., Lidfeldt J., Nerbrand C., et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ. Health Perspect. 2005, 113:1627-1631.
4. Adebamowo E.O., Agbede O.E., Sridhar M.K.C., Adebamowo C.A. Questionnaire survey of exposure to lead in the domestic environment in Nigeria. Sci. Total Environ. 2006, 372:94-99.
5. Buchet J.P., Lauwerys R., Roels H., Bernard A., Bruaux P., Claeys F., et al. Renal effects of cadmium body burden of the general population. Lancet 1990, 336:699-702.
6. Bartels H., Bohmer M. Eine mikromethode zur kreatinin bestimmung. Clin. Chim. Acta 1971, 32:81-85. (in German).
7. Bernard A. Confusion about cadmium risks: the unrecognized limitaions of an extrapolated paradigm. Environ. Health Perspect. 2015, 10.1289/ehp.1509691.
8. Coe F.L., Evan A., Worcester E. Kidney stone disease. J. Clin. Investig. 2005, 115:2598-2608.
9. Dirks J., Remuzzi G., Horton S., Schieppati A., Abdibul Hasan Rizvi S. Diseases of the kidney and the urinary system. Disease Control Priorities in Developing Countries 2006, 695-706. World Bank, Washington, D.C. D.T. Jamison, J.G. Breman, A.R. Measham, G. Alleyne, M. Claeson, D.B. Evans, P. Jha, A. Mills, P. Musgrove (Eds.).
10. Elinder C.G., Edling C., Lindberg E., Kagedal B., Vesterberg O. Assessment of renal function in workers previously exposed to cadmium. Br. J. Ind. Med. 1985, 42:754-760.
11. Emmerson B.T., Mirosch W., Douglas J.B. The relative contributions of tubular reabsorption and secretion to urate excretion in lead nephropathy. Aust. N. Z. J. Med. 1971, 4:353-362.
12. Ferraro P.M., Bonello M., Frigo A.C., D'Addessi A., Sturniolo A., Gambaro G. Cadmium exposure and kidney stone formation in the general population--an analysis of the National Health and Nutrition Examination Survey III data. J. Endourol. 2011, 25:875-880.
13. Frost C., Thompson S.G. Correcting for regression dilution bias: comparison of methods for a single predictor variable. J. R. Stat. Soc. A 2000, 163(Part 2):173-189.
14. Gasowski J., Li Y., Kuznetsova T., Richart T., Thijs L., Grodzicki T., et al. Is "usual" blood pressure a proxy for 24-hour ambulatory blood pressure in predicting cardiovascular outcomes?. Am. J. Hypertens. 2008, 21:994-1000.
15. Giannossi M.L., Summa V., Mongelli G. Trace element investigations in urinary stones: a preliminary pilot case in Basilicata (Southern Italy). J. Trace Elem. Med. Biol. 2013, 27:91-97.
16. Gartside P.S. The relationship of blood lead levels and blood pressure in NHANES II: additional calculations. Environ. Health Perspect. 1988, 78:31-34.
17. Handlogten M.E., Shiraishi N., Awata H., Huang C., Miller R.T. Extracellular Ca(2+)-sensing receptor is a promiscuous divalent cation sensor that responds to lead. Am. J. Physiol. Ren. Physiol. 2000, 279:F1083-F1091.
18. Hogervorst J., Plusquin M., Vangronsveld J., Nawrot T., Cuypers A., Van Hecke E., et al. House dust as possible route of environmental exposure to cadmium and lead in the adult general population. Environ. Res. 2007, 103:30-37.
19. Hu H., Shih R., Rothenberg S., Schwartz B.S. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ. Health Perspect. 2007, 115:455-462.
20. Hambach R., Lison D., D'Haese P.C., Weyler J., De Graef E., De Schryver A., et al. Co-exposure to lead increases the renal response to low levels of cadmium in metallurgy workers. Toxicol. Lett. 2013, 222:233-238.
21. Hara A., Thijs L., Asayama K., Gu Y.M., Jacobs L., Zhang Z.Y., et al. Blood pressure in relation to environmental lead exposure in the National Health and Nutrition Examination Survey 2003 to 2010. Hypertension 2014, 65:62-69.
22. Jarup L., Elinder C.G. Incidence of renal stones among cadmium exposed battery workers. Br. J. Ind. Med. 1993, 50:598-602.
23. Jarup L., Persson B., Elinder C.G. Blood cadmium as an indicator of dose in a long-term follow-up of workers previously exposed to cadmium. Scand. J. Work Environ. Health 1997, 23:31-36.
24. Kaewnate Y., Niyomtam S., Tangvarasittichai O., Meemark S., Pingmuangkaew P., Tangvarasittichai S. Association of elevated urinary cadmium with urinary stone, hypercalciuria and renal tubular dysfunction in the population of cadmium-contaminated area. Bull. Environ. Contam. Toxicol. 2012, 89:1120-1124.
25. Lauwerys R.R., Amery A., Bernard A., Bruaux P., Buchet J.-P., Claeys F., et al. Health effects of environmental exposure to cadmium: objectives, design, and organization of the Cadmibel Study, a cross-sectional morbidity study carried out in Belgium from 1985 to 1989. Environ. Health Perspect. 1990, 87:283-289.
26. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150:604-612.
27. Lin J.L., Tan D.T., Ho H.H., Yu C.C. Environmental lead exposure and urate excretion in the general population. Am. J. Med. 2002, 113:563-568.
28. Lotan Y., Buendia Jiménez I., Lenoir-Wijnkoop I., Daudon M., Molinier L., Tack I., et al. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system. BJU Int. 2012, 110:E1060.
29. Moe O.W. Kidney stones: pathophysiology and medical management. Lancet 2006, 367:333-344.
30. Mandel N.S., Mandel G.S. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J. Urol. 1989, 142:1516-1521.
31. May-Ix L.A., Rosado-Rubio J.G., Medina-Escobedo M., Castellanos-Ruelas A.F., Chel-Guerrero L.A., Betancur-Ancona D.A. Heavy metal quantification in renal tissue of patients in the state of Yucatan and its association with urolithiasis. ISRN Toxicol. 2012, 2012:548256.
32. Muntner P., Menke A., DeSalvo K.B., Rabito F.A., Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch. Intern Med. 2005, 165:2155-2161.
33. Mortada W.I., Sobh M.A., El-Defrawy M.M. The exposure to cadmium, lead and mercury from smoking and its impact renal integrity. Med. Sci. Monit. 2004, 10:CR112-CR116.
34. Nawrot T., Plusquin M., Hogervorst J., Roels H.A., Celis H., Thijs L., et al. Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol. 2006, 7:119-126.
35. Pak C.Y. Kidney stones. Lancet 1998, 351:1797-1801.
36. Pak C.Y., Poindexter J.R., Adams-Huet B., Pearle M.S. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am. J. Med. 2003, 115:26-32.
37. Pirkle J.L., Brody D.J., Gunter E.W., Kramer R.A., Paschal D.C., Flegal K.M., et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). J. Am. Med. Assoc. 1994, 272:284-291.
38. Romero V., Akpinar H., Assimos D.G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev. Urol. 2010, 12:e86-e96.
39. Renkema K.Y., Bindels R.J., Hoenderop J.G. Role of the calcium-sensing receptor in reducing the risk for calcium stones. Clin. J. Am. Soc. Nephrol. 2011, 6:2076-2082.
40. Rosen J.F. The metabolism of lead in isolated bone cell populations: interactions between lead and calcium. Toxicol. Appl. Pharmacol. 1983, 71:101-112.
41. Rahman S., Khalid N., Zaidi J.H., Ahmad S., Iqbal M.Z. Non-occupational lead exposure and hypertension in Pakistani adults. J. Zhejiang Univ. Sci. B 2006, 7:732-737.
42. Stamatelou K.K., Francis M.E., Jones C.A., Nyberg L.M., Curhan G.C. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003, 63:1817-1823.
43. Sorensen M.D., Chi T., Shara N.M., Wang H., Hsi R.S., Orchard T., et al. Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women's Health Initiative. J. Am. Soc. Nephrol. 2014, 25:362-369.
44. Staessen J., Amery A., Bernard A., Bruaux P., Buchet J.P., Bulpitt C.J., et al. Effects of exposure to cadmium on calcium metabolism: a population study. Br. J. Ind. Med. 1991, 45:710-714.
45. Staessen J.A., Roels H.A., Emelianov D., Kuznetsova T., Thijs L., Vangronsveld J., et al. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Lancet 1999, 353:1140-1144.
46. Schutte R., Nawrot T.S., Richart T., Thijs L., Vanderschueren D., Kuznetsova T., et al. Bone resorption and environmental exposure to cadmium in women: a population study. Environ. Health Perspect. 2008, 116:777-783.
47. Staessen J.A., Lauwerys R.R., Buchet J.-P., Bulpitt C.J., Rondia D., Vanrenterghem Y., et al. Impairment of renal function with increasing blood lead concentrations in the general population. N. Engl. J. Med. 1992, 327:151-156.
48. Staessen J.A., Lauwerys R.R., Ide G., Roels H.A., Vyncke G., Amery A. Renal dysfunction and historical environmental pollution from zinc smelters. Lancet 1994, 343:1523-1527.
49. Staessen J.A., Roels H., Fagard R. Lead exposure and the conventional and ambulatory blood pressure: a prospective population study. PheeCad Investigators. J. Am. Med. Assoc. 1996, 275:1563-1570.
50. Staessen J.A., Wang J.G., Brand E., Barlassina C., Birkenhager W.H., Hermann S.M., et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J. Hypertens. 2001, 19:1349-1358.
51. Staessen J., Bulpitt C., Fagard R., Joossens J.V., Lijnen P., Amery A. Four urinary cations and blood pressure: a population study in two Belgian towns. Am. J. Epidemiol. 1983, 117:676-687.
52. Stolarz-Skrzypek K., Kuznetsova T., Thijs L., Tikhonoff V., Seidlerová J., Richart T., et al. Fatal and nonfatal outcomes, incidence of hypertension and blood pressure changes in relation to urinary sodium excretion in White Europeans. J. Am. Med. Assoc. 2011, 305:1777-1785.
53. Staessen J.A., Kuznetsova T., Roels H.A., Emelianov D., Fagard R. Exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study. Am. J. Hypertens. 2000, 13:146-156.
54. Scott R., Cunningham C., McLelland A., Fell G.S., Fitzgerald-Finch O.P., McKellar N. The importance of cadmium as a factor in calcified upper urinary tract stone disease-a prospective 7-year study. Br. J. Urol. 1982, 54:584-589.
55. Thomas L.D., Elinder C.G., Tiselius H.G., Wolk A., Akesson A. Dietary cadmium exposure and kidney stone incidence: a population-based prospective cohort study of men & women. Environ. Int. 2013, 59:148-151.
56. Tiselius H.G. Who forms stones and why?. Eur. Urol. Suppl. 2011, 10:408-414.
57. Tellez-Plaza M., Navas-Acien A., Caldwell K.L., Menke A., Muntner P., Guallar E. Reduction in cadmium exposure in the United States population, 1988-2008: the contribution of declining smoking rates. Environ. Health Perspect. 2012, 120:204-209.
58. Van de Putte B., Miles A. Social Power and Class Formation in the Nineteenth Century. How to Measure Class From Occupation? 2006, Centrum voor Sociologisch Onderzoek, Centre for Population and Family Research, University of Leuven, Leuven, Belgium.
59. Wedeen R.P., Maesaka J.K., Weiner B., Lipat G.A., Lyons M.M., Vitale L.F., et al. Occupational lead nephropathy. Am. J. Med. 1975, 59:630-641.
60. Walker V., Stansbridge E.M., Griffin D.G. Demography and biochemistry of 2800 patients from a renal stones clinic. Ann. Clin. Biochem. 2013, 50:127-139.